Skip to main content

Table 2 Radiation dosimetry of [11C]OHB. Absorbed dose estimates and effective doses in humans

From: Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-11C]β-hydroxybutyrate ([11C]OHB) PET in healthy humans

Target organ

Intravenous (\(\upmu\)Sv/MBq)

Oral (\(\upmu\)Sv/MBq)

Adrenals

4.03 \(\pm \hspace{0.17em}\)0.24

5.41 \(\pm \hspace{0.17em}\)1.13

Brain

2.21 \(\pm \hspace{0.17em}\)0.17

1.82 \(\pm \hspace{0.17em}\)0.41

Breasts

2.94 \(\pm \hspace{0.17em}\)0.03

2.32 \(\pm \hspace{0.17em}\)0.22

Esophagus

3.21 \(\pm \hspace{0.17em}\)0.04

3.95 \(\pm \hspace{0.17em}\)0.69

Eyes

2.73 \(\pm \hspace{0.17em}\)0.02

1.82 \(\pm \hspace{0.17em}\)0.40

Gallbladder wall

3.54 \(\pm \hspace{0.17em}\)0.08

3.71 \(\pm \hspace{0.17em}\)0.22

Left colon

3.68 \(\pm \hspace{0.17em}\)0.03

5.40 \(\pm \hspace{0.17em}\)0.57

Small intestine

3.50 \(\pm \hspace{0.17em}\)0.03

28.47 \(\pm \hspace{0.17em}\)9.54

Stomach wall

3.63 \(\pm \hspace{0.17em}\)0.07

77.70 \(\pm \hspace{0.17em}\)47.19

Right colon

3.54 \(\pm \hspace{0.17em}\)0.02

3.32 \(\pm \hspace{0.17em}\)0.53

Rectum

3.49 \(\pm \hspace{0.17em}\)0.05

2.86 \(\pm \hspace{0.17em}\)0.54

Heart wall

8.11 \(\pm \hspace{0.17em}\)1.66

6.38 \(\pm \hspace{0.17em}\)1.36

Kidneys

6.45 \(\pm \hspace{0.17em}\)0.99

4.68 \(\pm \hspace{0.17em}\)0.60

Liver

3.29 \(\pm \hspace{0.17em}\)0.68

3.69 \(\pm \hspace{0.17em}\)0.68

Lungs

3.18 \(\pm \hspace{0.17em}\)0.02

3.21 \(\pm \hspace{0.17em}\)0.26

Ovaries

3.89 \(\pm \hspace{0.17em}\)0.05

3.40 \(\pm \hspace{0.17em}\)0.61

Pancreas

8.22 \(\pm \hspace{0.17em}\)2.14

9.15 \(\pm \hspace{0.17em}\)2.95

Prostate

3.09 \(\pm \hspace{0.17em}\)0.04

2.42 \(\pm \hspace{0.17em}\)0.44

Salivary glands

5.91 \(\pm \hspace{0.17em}\)2.26

2.25 \(\pm \hspace{0.17em}\)0.92

Red marrow

4.23 \(\pm \hspace{0.17em}\)0.43

2.42 \(\pm \hspace{0.17em}\)0.17

Osteogenic cells

3.10 \(\pm \hspace{0.17em}\)0.24

1.87 \(\pm \hspace{0.17em}\)0.18

Spleen

7.75 \(\pm \hspace{0.17em}\)3.06

6.39 \(\pm \hspace{0.17em}\)1.99

Testes

2.67 \(\pm \hspace{0.17em}\)0.04

1.78 \(\pm \hspace{0.17em}\)0.40

Thymus

3.35 \(\pm \hspace{0.17em}\)0.05

2.62 \(\pm \hspace{0.17em}\)0.21

Thyroid

3.04 \(\pm \hspace{0.17em}\)0.03

2.16 \(\pm \hspace{0.17em}\)0.34

Urinary bladder wall

3.47 \(\pm \hspace{0.17em}\)0.53

2.52 \(\pm \hspace{0.17em}\)0.56

Uterus

3.83 \(\pm \hspace{0.17em}\)0.05

3.59 \(\pm \hspace{0.17em}\)0.68

Total body

3.18 \(\pm \hspace{0.17em}\)0.00

3.13 \(\pm \hspace{0.17em}\)0.03

Effective dose

3.28 \(\pm \hspace{0.17em}\)0.09

12.51 \(\pm \hspace{0.17em}\)5.90

  1. Mean intravenous dose was 204.2 MBq (range, 182–222) and mean oral dose was 96.11 MBq (range, 59.15–114.5). Values are mean \(\pm\) SD